A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer

Introduction: Platinum-based chemotherapy (PBC) remains the mainstay of treatments for triple-negative breast cancer (TNBC). TNBC is a heterogeneous group, the issue of whether BRCA1/2 mutation carriers have a particular sensitivity to platinum agents is inconclusive. We conducted a meta-analysis to...

Cijeli opis

Bibliografski detalji

Glavni autori:	Xiaomeng Jia, Kainan Wang, Lingzhi Xu, Ning Li, Zuowei Zhao, Man Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2022-12-01
Serija:	Breast
Teme:	Triple-negative breast cancer Platinum BRCA1/2 mutation
Online pristup:	http://www.sciencedirect.com/science/article/pii/S0960977622001424
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!